How Diabetes Medications Including GLP-1 Drugs Affect Skin Conditions
GLP-1 and GLP-1/GIP agonists have hormonal and immune effects that may benefit skin diseases like psoriasis and hidradenitis suppurativa.
Quick Facts
What This Study Found
GLP-1 and dual GLP-1/GIP agonists have immune-modulating effects that may benefit inflammatory skin diseases while also causing potential dermatologic side effects.
Key Numbers
No specific trial data reported; qualitative review of case reports and small studies.
How They Did This
Narrative review of dermatologic adverse effects and therapeutic benefits of T2DM medications.
Why This Research Matters
With millions on GLP-1 drugs, dermatologists and endocrinologists need to understand skin-related effects — both beneficial and adverse.
The Bigger Picture
The anti-inflammatory properties of GLP-1 drugs may open unexpected dermatologic applications, adding to their growing list of potential benefits.
What This Study Doesn't Tell Us
Narrative review — evidence quality varies. Most dermatologic data comes from case reports and small studies rather than large trials.
Questions This Raises
- ?Should GLP-1 drugs be preferentially prescribed for diabetic patients with psoriasis?
- ?What dermatologic monitoring should accompany GLP-1 therapy?
Trust & Context
- Key Stat:
- Dual effects GLP-1 drugs may improve inflammatory skin diseases while also causing dermatologic side effects
- Evidence Grade:
- Narrative review — useful clinical overview but evidence for dermatologic effects is still early-stage.
- Study Age:
- Published in 2025, capturing emerging observations about skin effects of newer diabetes medications.
- Original Title:
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus.
- Published In:
- Cutis, 115(1), 7-13 (2025)
- Authors:
- Ponce, Mayra Betancourt, Shields, Bridget E
- Database ID:
- RPEP-13077
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Can GLP-1 drugs help with skin conditions?
Early evidence suggests their anti-inflammatory effects may benefit conditions like psoriasis and hidradenitis suppurativa, though more research is needed.
Do GLP-1 drugs cause skin problems?
Some dermatologic side effects have been reported, but the drugs may also benefit certain inflammatory skin conditions — effects go both ways.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13077APA
Ponce, Mayra Betancourt; Shields, Bridget E. (2025). Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus.. Cutis, 115(1), 7-13. https://doi.org/10.12788/cutis.1148
MLA
Ponce, Mayra Betancourt, et al. "Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus.." Cutis, 2025. https://doi.org/10.12788/cutis.1148
RethinkPeptides
RethinkPeptides Research Database. "Dermatologic Implications of Glycemic Control Medications fo..." RPEP-13077. Retrieved from https://rethinkpeptides.com/research/ponce-2025-dermatologic-implications-of-glycemic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.